2026 / 05

DOI: 10.24075/brsmu.2026.057
Copyright: © 2026 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Effect of dexamethasone on plasma C-reactive protein concentrations in rats with arthrosis combined with obesity

Ivanov AS1,2,3 , Tananakina TP3 , Kashchenko SA3 , Pogorelova IA3 , Alexandrov IA1
About authors

1 Scientific and Diagnostic Center "Polyclinic on Smolenskaya", Moscow, Russia

2 MEDSI Clinic, Clinical Hospital No. 1, Krasnogorsk, Russia

3 St. Luke Lugansk State Medical University, Russia

Correspondence should be addressed: Aleksey S. Ivanov
Stolyarny pereulok, 7, str. 2, Moscow, 123022, Russia; ur.liam@5891golotamvartahsas

About paper

Author contribution: Ivanov AS — study planning and design, literature review, experimental procedure; Tananakina TP — study planning and design, experimental procedure, research support, manuscript writing; Kashchenko SA — scientific editing, advice on the experimental procedure, manuscript writing; Pogorelova IA — calculation of results, drug dose selection and titration, advice on animal handling; Alexandrov IA — experimental animal handling, drug administration, blood sampling for analysis, contribution to withdrawal of animals from the experiment.

Compliance with ethical standards: the study approved by the Ethics Committee of the St. Luke Lugansk State Medical University (protocol No. 2 dated September 23, 2025) was fully compliant with the Eurasian Economic Commission (EEC) Board "Guidelines for the Use of Laboratory (Experimental) Animals in Preclinical (NonClinical) Studies" dated November 14, 2023, No. 33, principles of the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes, s well as the Directive of the European Parliament and of the Council of the European Union on the Protection of Animals Used for Scientific Purposes.

Received: 2026-08-27 Accepted: 2026-10-05 Published online: 2026-10-19
|
  1. Plebani M. Why C-reactive protein is one of the most requested tests in clinical laboratories? Clinical Chemistry and Laboratory Medicine (CCLM). 2023; 61 (9): 1540–5. DOI: 10.1515/cclm-2023-0086.
  2. Orbelyan LK, Durleshter VM, Bykov IM (ml.). Rannee prognozirovanie iskhodov ostrogo pankreatita raznoj etiologii: retrospektivnoe observacionnoe issledovanie. Kubanskij nauchnyj medicinskij vestnik. 2025; 32 (2): 41–54. DOI: 10.25207/1608-6228-2025-32-2-41-54. Russian.
  3. Suthahar N, Wang D, Aboumsallem JP, et al. Association of initial and longitudinal changes in C-reactive protein with the risk of cardiovascular disease, cancer, and mortality. Mayo Clin Proc. 2023; 98 (4): 549–58. DOI: 10.1016/j.mayocp.2022.10.013.
  4. Kurniawan RB, Oktafia P, Saputra PBT, et al. The roles of C-reactive protein-albumin ratio as a novel prognostic biomarker in heart failure patients: A systematic review. Curr Probl Cardiol. 2024; 49 (5): 102475. DOI: 10.1016/j.cpcardiol.2024.102475.
  5. Ogdie A, Tillett W, Booth N, et al. Usage of C-reactive protein testing in the diagnosis and monitoring of psoriatic arthritis (PsA): results from a real-world survey in the USA and Europe. Rheumatol Ther. 2022; 9 (1): 285–93. DOI: 10.1007/s40744-021-00420-x.
  6. Gialouri CG, Evangelatos G, Pappa M, et al. Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice. Ther Adv Musculoskelet Dis. 2022; 14: 1759720X221122417. DOI: 10.1177/1759720X221122417.
  7. Pastorello Y, Carare RO, Banescu C, et al. Monomeric C-reactive protein: A novel biomarker predicting neurodegenerative disease and vascular dysfunction. Brain Pathology. 2023; 33 (6): e13164. DOI: 10.1111/bpa.13164.
  8. Fujita C, Sakurai Y, Yasuda Y, Fujita M. Monomeric C-reactive protein as a therapeutic target in inflammatory diseases. RMD Open. 2025; 11: e005379. DOI: 10.1136/rmdopen-2024-005379.
  9. Slevin M, Heidari N, Azamfirei L. Monomeric C-reactive protein: current perspectives for utilization and inclusion as a prognostic indicator and therapeutic target. Front Immunol. 2022; 13: 866379. DOI: 10.3389/fimmu.2022.866379.
  10. Pohanka M. Diagnoses based on C-reactive protein point-of-care tests. Biosensors. 2022; 12: 344. DOI: 10.3390/bios12050344.
  11. Cooper J, Pastorello Y, Slevin M. A meta-analysis investigating the relationship between inflammation in autoimmune disease, elevated CRP, and the risk of dementia. Front Immunol. 2023; 14: 1087571. DOI: 10.3389/fimmu.2023.1087571.
  12. Kharel S, Ojha R, Preethish-Kumar V, Bhagat R. C-reactive protein levels in patients with amyotrophic lateral sclerosis: A systematic review. Brain Behav. 2022; 12 (3): e2532. DOI: 10.1002/brb3.2532.
  13. Yang M, Qiu S, He Y, et al. Genetic ablation of C-reactive protein gene confers resistance to obesity and insulin resistance in rats. Diabetologia. 2021; 64 (5): 1169–83. DOI: 10.1007/s00125-021-05384-9.
  14. Verma S, Bhatta M, Davies M, et al. Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials. E Clinical Medicine. 2022; 55: 101737. DOI: 10.1016/j.eclinm.2022.101737.
  15. Bay-Jensen AC, Bihlet A, Byrjalsen I, et al. Serum C-reactive protein metabolite (CRPM) is associated with incidence of contralateral knee osteoarthritis. Sci Rep. 2021; 11 (1): 6583. DOI: 10.1038/s41598-021-86064-x.
  16. Bondorenko DV, Ivanov AS, Tananakina TP, Kashchenko SA, Pogorelova IA, Alexandrov IA. The effect of diclofenac sodium on bone marrow cellularity, the LSK cell pool, and cytokine profiles in mice with experimental dermatitis. Bulletin of RSMU. 2026; 3: 129–35. DOI: 10.24075/brsmu.2026.038.
  17. Ivanov O, Haidash O, Voloshin V, Kondratov S, Smirnov A. Influence of then acting substance sodium diclofenac on bone marrow cells. Georgian Med News. 2020; 306: 137–42. PMID: 33130661.
  18. Ivanov AS, Tananakina TP, Kashchenko SA, Pogorelova IA. Expression of microRNA miR146a in the blood plasma of rats with obesity and knee arthrosis after administration of dexamethasone. Bulletin of RSMU. 2025; 6: 209–15. DOI: 10.24075/brsmu.2025.056.
  19. Madamsetty Vijay Sagar Mohammadinejad, Reza Uzieliene, Ilona Nabavi, et al. Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems. ACS biomaterials science & engineering. 2022; 8 (5): 1763–90. DOI: 10.1021/acsbiomaterials.2c00026.
  20. Muzammil Kabier, Shamili Mariya Varghese, Athira KV, et al. OpenFieldAI — new open-source AI based software for tracking rodents and training open field test models. Journal of Neuroscience Methods. 2026; 428: 110667. DOI: 10.1016/j.jneumeth.2025.110667.
  21. Magamedov ID, Pivovarova LP, Nohrin SP, i dr. Faktory vospaleniya, adgezivnosti i tromboza pri ostroj ishemii nizhnih konechnostej i terapii deksametazonom. Rossijskij immunologicheskij zhurnal. 2022; 25 (3): 251–8. DOI: 10.46235/1028-7221-1117-FOI. Russian.
  22. Rosenberg AS. From mechanism to resistance — changes in the use of dexamethasone in the treatment of multiple myeloma. Leuk Lymphoma. 2023; 64 (2): 283–91. DOI: 10.1080/10428194.2022.2136950.
  23. Lee RA, Chang M, Tsay A, Lee YR, Li D, Yiv N, et al. Chronic Glucocorticoid Exposure Induced an S1PR2-RORγ Axis to Enhance Hepatic Gluconeogenesis in Male Mice. Diabetes. 2023; 72 (11): 1534–46. DOI: 10.2337/db22-0605.
  24. Rumyancev EE, Merbah SV, Iskandaryan AK, Proshina LG, Kartysheva K Yu. Osnovnye markery vospaleniya u bol'nyh s COVID-19 i serdechno-sosudistoj komorbidnost'yu pri lechenii glyukokortikosteroidami i kombinaciej glyukokortikosteroidov s genno-inzhenernymi biologicheskimi preparatami. Vestnik NovGU. Ser.: Medicinskie nauki. 2022; 4 (129): 23–26. DOI: 10.34680/2076-8052.2022.4(129).23-26. Russian.
  25. Vecchié A, Batticciotto A, Tangianu F, et al. High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study. Intern Emerg Med. 2021; 16: 1913–9. DOI: 10.1007/s11739-021-02800-1.
  26. Mirjana Cihoric, Henrik Kehlet, Morten L Lauritsen, et al. Preoperative high dose of dexamethasone in emergency laparotomy: randomized clinical trial. BJS. 2024; 111 (7): znae130. DOI: 10.1093/bjs/znae130.
  27. Niklas I. Nielsen, Henrik Kehlet et al. High-dose dexamethasone in low pain responders undergoing total knee arthroplasty: a randomised double-blind trial. British Journal of Anaesthesia. 2023; 130 (3): 322–30. DOI: 10.1016/j.bja.2022.10.038.